Stage IB Non-Small Cell Lung Carcinoma AJCC v7
4 clinical trials · Condition
◉ Watch Stage IB Non-Small Cell Lung Carcinoma AJCC v7
| Record | Firm | Date |
|---|---|---|
| Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy (NCT03493789) | Emory University | 2018-04-13 |
| Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer (NCT03348748) | Roswell Park Cancer Institute | 2017-12-18 |
| Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-IIIA Non-small Cell Lung Cancer (NCT02225405) | M.D. Anderson Cancer Center | 2015-04-03 |
| Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) (NCT02201992) | ECOG-ACRIN Cancer Research Group | 2015-03-23 |
Track Stage IB Non-Small Cell Lung Carcinoma AJCC v7 automatically
Every clearance here is in the API, with alerts when new ones post.